Supreme Court Report

Supreme Court of the United States · Official docket →

Pfizer Inc. v. Alida Adamyan, et al.

Paid petition · United States Court of Appeals for the Ninth Circuit, No. 18-80059 · judgment August 22, 2018


Certiorari denied · October 7, 2019
Pre-decision estimate: 12% cert probability (95% interval 9%–16%)

Before the decision, about 3× the 4.1% base rate. The model weighted this up for a Ninth Circuit decision below, a circuit split argued in the petition, and a dissent in the court below (flagged in the petition).

Question presented

This Petition presents an important, unsettled, and recurring question concerning the “mass action” provisions of the Class Action Fairness Act (CAFA). Under CAFA, a removable “mass action” is a minimally diverse civil action in which the monetary claims of 100 or more persons are “proposed to be tried jointly on the ground that the plaintiffs’ claims involve common questions of law or fact.” 28 U.S.C. § 1332(d)(11). The courts of appeals are divided as to whether a sua sponte proposal by a state court—as opposed to a proposal by plaintiffs—can trigger mass action removal. Here, Pfizer removed these cases involving more than 4,200 products liability plaintiffs following a California state court’s “Request” to coordinate them all before a single trial judge. But the district court remanded the litigation to state court based on its view that a state court’s proposal for joint trial cannot trigger removal under CAFA, and the Ninth Circuit declined to correct the district court’s misreading of the statute. The question presented is whether a state court’s proposal to try jointly the claims of more than 100 plaintiffs can qualify for “mass action” removal under the Class Action Fairness Act, 28 U.S.C. § 1332(d)(11).

Counsel of record

For petitioner
Michael Hugh McGinley
Dechert LLP

For respondent
Jules Burton LeBlanc IV
Baron & Budd, P.C.

Case

Conference history
Distributed for 1 conference

Amicus briefs
2 cert-stage

Linked docket
18A980

Proceedings

  1. Oct 07 2019
    Petition DENIED.
  2. Sep 11 2019
    DISTRIBUTED for Conference of 10/1/2019.
  3. Sep 10 2019
    Reply of petitioner Pfizer, Inc. filed.
  4. Aug 26 2019
    Brief of respondents Alida Adamyan, et al. in opposition filed.
  5. Jul 25 2019
    Brief amici curiae of American Tort Reform Association, et al. filed.
  6. Jul 25 2019
    Brief amicus curiae of Washington Legal Foundation filed.
  7. Jul 15 2019
    Motion to extend the time to file a response is granted and the time is extended to and including August 26, 2019.
  8. Jul 09 2019
    Motion to extend the time to file a response from July 25, 2019 to August 24, 2019, submitted to The Clerk.
  9. Jun 21 2019
    Petition for a writ of certiorari filed. (Response due July 25, 2019)
  10. Mar 28 2019
    Application (18A980) granted by Justice Kagan extending the time to file until June 21, 2019.
  11. Mar 25 2019
    Application (18A980) to extend the time to file a petition for a writ of certiorari from April 22, 2019 to June 21, 2019, submitted to Justice Kagan.